Skip to main content
. 2013 Jan 4;8(1):e52801. doi: 10.1371/journal.pone.0052801

Table 4. Difference in the scores of BASDAI, BASFI, and BAS-G among AS patients stratified by rs4552569 and rs17095830 genotypes.

SNP Genotype BASDAI BASFI BAS-G
rs4552569 CC 4.89±1.92 2.24±2.05 4.38±2.46
CT 4.34±2.22 2.07±2.22 4.52±2.79
TT 4.20±2.20 2.01±2.18 4.27±2.75
Unadjusted P-value 0.2393 0.8297 0.6436
Adjusted P-value 0.2387 0.7625§ 0.6405
rs17095830 GG 3.91±3.23 2.93±4.39 4.12±4.62
AG 4.62±2.22 2.09±2.08 4.58±2.94
AA 4.26±2.18 2.04±2.19 4.36±2.68
Unadjusted P-value 0.3610 0.6202 0.7779
Adjusted P-value 0.3602 0.9494§ 0.7757
Two-locus model
High-risk group 4.34±2.19b 2.17±2.28b 4.49±2.94b
Low-risk group 4.01±2.17b 2.02±2.17b 4.36±2.71b
Unadjusted P-value 0.0266 0.5832 0.7235
Adjusted P-value 0.0264 0.5077§ 0.7222

Data represent means ± S.D..

Adjusted the effects of age and sex.

§

Adjusted the effects of age, sex and disease duration. 0.025Inline graphic P<0.05 values are in bold.

b

AS patients with the CC genotype of rs4552569, GG genotype of rs17095830 or heterozygous at both loci were classified into high-risk group and the others were classified into low- risk group.